| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | MYO7A MYO9A MYO10 SPTA1 SPTB GAS2 ITPRID2 FGD4 AVIL MACF1 TRPV4 | 1.36e-05 | 227 | 193 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | VAPB HAUS6 MYO7A MYO9A MYO10 SPTA1 SPTB GAS2 LRRK2 GAS8 OBSCN CLSTN2 ITPRID2 TUBGCP2 PTK2 PTPRC BMP10 FGD4 SYNE2 UTRN KIF16B AVIL MACF1 TRPV4 MX1 KIF1C | 2.21e-05 | 1099 | 193 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYO7A MYO9A MYO10 SPTA1 SPTB GAS2 LRRK2 ITPRID2 PTK2 FGD4 SYNE2 UTRN AVIL MACF1 TRPV4 | 6.84e-05 | 479 | 193 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.08e-04 | 49 | 193 | 5 | GO:0005547 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | HIPK1 RPS6KA3 LRRK2 OBSCN MELK PIK3R4 PHKG2 RPS6KA6 AKT1 ULK1 HIPK4 PDPK2P BRD2 PRKDC | 1.17e-04 | 446 | 193 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.51e-04 | 118 | 193 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule binding | VAPB HAUS6 GAS2 LRRK2 GAS8 TUBGCP2 KIF16B MACF1 TRPV4 MX1 KIF1C | 2.13e-04 | 308 | 193 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | kinase activity | HIPK1 RPS6KA3 LRRK2 OBSCN GCK MELK PTK2 PIK3R4 PHKG2 RPS6KA6 ALDH18A1 AKT1 ULK1 HIPK4 PDPK2P BRD2 PRKDC PALS2 | 4.59e-04 | 764 | 193 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | HIPK1 RPS6KA3 LRRK2 OBSCN MELK PTK2 PIK3R4 PHKG2 RPS6KA6 AKT1 ULK1 HIPK4 PDPK2P BRD2 PRKDC | 7.58e-04 | 600 | 193 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine kinase activity | HIPK1 RPS6KA3 LRRK2 OBSCN MELK PIK3R4 RPS6KA6 AKT1 ULK1 HIPK4 PRKDC | 8.43e-04 | 363 | 193 | 11 | GO:0106310 |
| GeneOntologyCellularComponent | cell cortex | MYO7A MYO10 ERC1 SPTA1 SPTB GCK MELK PTK2 AKT1 GRB2 PDE4DIP MACF1 TRPV4 RIMS2 | 1.08e-05 | 371 | 195 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | filopodium | 1.57e-04 | 123 | 195 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | supramolecular fiber | HAUS6 MYO9A GAS2 GAS8 OBSCN GCK DBI TUBGCP2 CMYA5 KAT2B BMP10 SYNE2 DNAH10 KIF16B DNAH1 AVIL PDE4DIP CCT8 MACF1 TRPV4 TUBE1 MX1 AHNAK2 KIF1C | 2.72e-04 | 1179 | 195 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | HAUS6 MYO9A GAS2 GAS8 OBSCN GCK DBI TUBGCP2 CMYA5 KAT2B BMP10 SYNE2 DNAH10 KIF16B DNAH1 AVIL PDE4DIP CCT8 MACF1 TRPV4 TUBE1 MX1 AHNAK2 KIF1C | 3.00e-04 | 1187 | 195 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | lamellipodium | 3.21e-04 | 230 | 195 | 9 | GO:0030027 | |
| Domain | Spectrin | 3.24e-06 | 23 | 193 | 5 | PF00435 | |
| Domain | CH | 1.03e-05 | 73 | 193 | 7 | PS50021 | |
| Domain | Spectrin_repeat | 1.09e-05 | 29 | 193 | 5 | IPR002017 | |
| Domain | CH-domain | 1.24e-05 | 75 | 193 | 7 | IPR001715 | |
| Domain | SPEC | 1.80e-05 | 32 | 193 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.80e-05 | 32 | 193 | 5 | IPR018159 | |
| Domain | CH | 5.61e-05 | 65 | 193 | 6 | SM00033 | |
| Domain | ACTININ_2 | 8.39e-05 | 23 | 193 | 4 | PS00020 | |
| Domain | ACTININ_1 | 8.39e-05 | 23 | 193 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.39e-05 | 23 | 193 | 4 | IPR001589 | |
| Domain | CH | 8.53e-05 | 70 | 193 | 6 | PF00307 | |
| Domain | - | 9.24e-05 | 71 | 193 | 6 | 1.10.418.10 | |
| Pubmed | RABEP2 ERG ERC1 SPTB EHD2 SAFB ALDH18A1 UTRN HSPA4 SF3B2 PPFIBP1 MACF1 PRKDC LRRFIP1 AHNAK2 | 3.04e-09 | 360 | 199 | 15 | 33111431 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF346 HAUS6 MYCBP2 ERC1 HNRNPA1 PTK2 WIZ ASCC2 DNAJC13 LIMD1 PATL1 PPP1R10 IBTK RRN3 UTP4 CCT8 UNK MACF1 LRRFIP1 AHNAK2 | 8.07e-09 | 724 | 199 | 20 | 36232890 |
| Pubmed | VAPB BNC2 ZNF346 UGGT1 TM7SF3 PTK2 DMXL1 ZNF462 SAFB PLXNA1 CHD8 RNF220 DNAJC11 MACF1 | 9.99e-09 | 335 | 199 | 14 | 15741177 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | VAPB STAM2 HAUS6 ERC1 TIPRL HNRNPA1 SAFB WIZ UTRN HSPA4 SF3B2 LIMD1 POLDIP3 SMCHD1 THOC2 PPP1R10 IBTK UTP4 CCT8 MACF1 PRKDC AHNAK2 | 2.43e-08 | 934 | 199 | 22 | 33916271 |
| Pubmed | CPNE2 MYCBP2 SPTB PKD1L1 KIAA0586 LRRK2 OBSCN ETV1 GON4L COPS2 DMXL1 TASOR2 BNC1 SAFB TRANK1 GCLM AKT1 ADAM17 UTRN CHD8 TRIM33 RNF220 BRD2 PWWP3B RIMS2 | 3.56e-08 | 1215 | 199 | 25 | 15146197 | |
| Pubmed | KDM3A ERG MYCBP2 ERC1 HIPK1 SPTB CMYA5 PTK2 PIK3R4 GDAP1L1 WIZ USP32 UTRN SF3B2 PLEKHB2 RAP1GDS1 PPFIBP1 TRIM33 RNF220 BRD2 PDE4DIP MACF1 PRKDC PALS2 LRRFIP1 | 1.04e-07 | 1285 | 199 | 25 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KCNH8 MYCBP2 MYO9A SPTB TM7SF3 OBSCN ETV1 ADCY3 PTK2 TTC19 TASOR2 ZNF462 RPTOR UTRN UBR2 DNAJC13 LIMD1 PATL1 PPP4R4 DNAH1 ANKRD44 SLC35A3 FAM13A USP40 MACF1 ELK3 PALS2 | 1.26e-07 | 1489 | 199 | 27 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STAM2 CCDC8 MYCBP2 MYO9A ERC1 ITPRID2 MELK MEX3C PIK3R4 RPTOR SYNE2 UTRN HIPK4 LIMD1 PPFIBP1 PPP4R4 FAM13A MACF1 AHNAK2 KIF1C | 1.36e-07 | 861 | 199 | 20 | 36931259 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYCBP2 ERC1 PKD1L1 F5 HNRNPA1 SAFB CPLANE1 DNAJC13 RASGRF1 POLDIP3 SMCHD1 MACF1 PRKDC | 1.91e-07 | 361 | 199 | 13 | 26167880 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ZSCAN5DP HPSE2 RGL1 RPS6KA6 UTRN RAP1GDS1 COL12A1 ZSCAN4 SMCHD1 KIF16B UTP4 PDE4DIP PWWP3B | 2.03e-07 | 363 | 199 | 13 | 14691545 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.28e-07 | 197 | 199 | 10 | 20811636 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | VAPB MYCBP2 ERC1 SPTA1 UGGT1 CLSTN2 HNRNPA1 SAFB ALDH18A1 UTRN HSPA4 CHD8 DNAH1 CCT8 MACF1 PRKDC PALS2 DISP1 AHNAK2 | 2.32e-07 | 807 | 199 | 19 | 30575818 |
| Pubmed | MYCBP2 UGGT1 PTK2 NUP205 SAFB DNAJC13 SMCHD1 THOC2 PRKDC LRRFIP1 | 2.88e-07 | 202 | 199 | 10 | 24639526 | |
| Pubmed | ERC1 TUBGCP2 TIPRL ALDH18A1 UTRN HSPA4 LIMD1 PPFIBP1 THOC2 ANKRD44 DNAJC11 UNK PRKDC KIF1C | 3.38e-07 | 446 | 199 | 14 | 24255178 | |
| Pubmed | 3.92e-07 | 160 | 199 | 9 | 31678930 | ||
| Pubmed | KDM3A ZSCAN12 MELK NUP205 TRANK1 PSME4 RPTOR SMCHD1 KIF16B CHD8 TRIM33 IBTK UNK RIMS2 MINDY1 | 4.63e-07 | 529 | 199 | 15 | 14621295 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCDC8 MYCBP2 UGGT1 ITPRID2 F5 HNRNPA1 NUP205 SAFB SYNE2 UTRN HSPA4 SF3B2 POLDIP3 SMCHD1 THOC2 PPP1R10 BRD2 UTP4 CCT8 MACF1 PRKDC | 5.05e-07 | 1024 | 199 | 21 | 24711643 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | VAPB HAUS6 ERC1 PKD1L1 DBI TUBGCP2 FHIP1B NUP205 GCLM CPLANE1 LIMD1 PPFIBP1 PATL1 CEP164 AP4E1 IBTK CCT8 UNK KIF1C | 5.36e-07 | 853 | 199 | 19 | 28718761 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A ERG MYCBP2 ITPRID2 SAFB PTPRC RPTOR SF3B2 ARHGEF6 DNAJC13 PATL1 THOC2 BRD2 FAM13A UNK ELK3 PRKDC LRRFIP1 | 5.85e-07 | 774 | 199 | 18 | 15302935 |
| Pubmed | Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis. | 7.35e-07 | 4 | 199 | 3 | 12711546 | |
| Pubmed | KDM3A STAM2 HAUS6 MYCBP2 ERC1 TIPRL WIZ LIMD1 SMCHD1 CHD8 THOC2 PPP1R10 CCT8 PRKDC LRRFIP1 | 7.37e-07 | 549 | 199 | 15 | 38280479 | |
| Pubmed | VAPB RABEP2 STAM2 CCDC8 MYCBP2 ERC1 UGGT1 ITPRID2 TIPRL PTPRC WIZ SYNE2 ALDH18A1 PDP2 UTRN UBR2 DNAJC13 GRB2 PPP4R4 PPP1R10 BRD2 | 7.43e-07 | 1049 | 199 | 21 | 27880917 | |
| Pubmed | VAPB ERC1 SPTA1 SPEF2 LIN54 UGGT1 HNRNPA1 TASOR2 NUP205 SAFB SYNE2 ULK1 SMCHD1 PPP4R4 ZNF675 BRD2 GSTK1 AVIL DNAJC11 CSPG4 VPS35 MACF1 PABPC1L PRKDC RIMS2 | 8.73e-07 | 1442 | 199 | 25 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYCBP2 MYO9A MELK HNRNPA1 PTK2 NUP205 PIK3R4 SAFB PSME4 RPTOR ALDH18A1 UTRN HSPA4 SF3B2 DNAJC13 POLDIP3 SMCHD1 CHD8 UTP4 VPS35 CCT8 MACF1 PRKDC AHNAK2 | 9.89e-07 | 1353 | 199 | 24 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CPNE2 ERC1 UGGT1 ITPRID2 TUBGCP2 F5 HNRNPA1 TASOR2 NUP205 SAFB ASCC2 ALDH18A1 SF3B2 POLDIP3 PPFIBP1 SMCHD1 THOC2 PPP1R10 UTP4 DNAJC11 CCT8 PRKDC LRRFIP1 | 1.00e-06 | 1257 | 199 | 23 | 36526897 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VAPB LIN54 UGGT1 DBI TIPRL COPS2 HNRNPA1 NUP205 SAFB SYNE2 ALDH18A1 UTRN HSPA4 SF3B2 DNAJC13 RAP1GDS1 POLDIP3 GSTK1 PTRH2 CCT8 PRKDC VPS28 LRRFIP1 AHNAK2 | 1.18e-06 | 1367 | 199 | 24 | 32687490 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RABEP2 MYO7A TOPAZ1 OBSCN COPS2 TTC19 PIK3R4 TRANK1 USP32 ASCC2 GRB2 PPP1R10 VPS35 MINDY1 | 1.22e-06 | 497 | 199 | 14 | 36774506 |
| Pubmed | MYCBP2 UGGT1 TASOR2 NUP205 SYNE2 ALDH18A1 UTRN HSPA4 SF3B2 POLDIP3 SMCHD1 CHD8 THOC2 UTP4 MACF1 PRKDC | 1.30e-06 | 653 | 199 | 16 | 22586326 | |
| Pubmed | STAM2 MYCBP2 HIPK1 PTPRC ASCC2 UTRN PLEKHB2 LIMD1 ZSCAN4 ZNF675 PPP1R10 CSPG4 VPS35 PDE4DIP MACF1 | 1.83e-06 | 591 | 199 | 15 | 15231748 | |
| Pubmed | VAPB RPS6KA3 UGGT1 ITPRID2 TUBGCP2 COPS2 NUP205 EHD2 SYNE2 ASCC2 ALDH18A1 PLOD2 HSPA4 POLDIP3 PPFIBP1 GRB2 THOC2 VPS35 PTRH2 CCT8 PRKDC MX1 LRRFIP1 AHNAK2 | 2.90e-06 | 1440 | 199 | 24 | 30833792 | |
| Pubmed | VAPB CPNE2 STAM2 PTK2 GCLM DNAJC13 PPFIBP1 GSTK1 CSPG4 PTRH2 PALS2 | 3.09e-06 | 325 | 199 | 11 | 36168628 | |
| Pubmed | 3.61e-06 | 209 | 199 | 9 | 36779422 | ||
| Pubmed | 3.64e-06 | 6 | 199 | 3 | 16962653 | ||
| Pubmed | RABEP2 STAM2 LAMA1 COPS2 USP32 ASCC2 PDP2 PDPK2P IBTK RNF220 USP40 MACF1 VPS28 | 4.63e-06 | 481 | 199 | 13 | 28190767 | |
| Pubmed | BNC2 ZNF346 ZSCAN12 ZSCAN5DP ETV1 ZNF354C ZNF462 KAT2B WIZ SF3B2 PLXNA1 LIMD1 PPP1R10 IBTK BRD2 ZKSCAN3 UNK | 4.64e-06 | 808 | 199 | 17 | 20412781 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | VAPB HNRNPA1 TASOR2 ZNF462 SAFB WIZ DNMT3A POLDIP3 CHD8 TRIM33 BRD2 PRKDC | 4.99e-06 | 411 | 199 | 12 | 35182466 |
| Pubmed | VAPB STAM2 CCDC8 MYCBP2 UGGT1 ITPRID2 HNRNPA1 DMXL1 SYNE2 ASCC2 PLOD2 HSPA4 SF3B2 DNAJC13 PPFIBP1 KIF16B GRB2 VARS2 BRD2 UTP4 DNAJC11 VPS35 PTRH2 MACF1 | 5.00e-06 | 1487 | 199 | 24 | 33957083 | |
| Pubmed | EPC2 HAUS6 MYCBP2 ERC1 GON4L F5 PHKG2 KAT2B UTRN ARHGEF6 DNMT3A SMCHD1 THOC2 PPP1R10 BRD2 | 5.27e-06 | 645 | 199 | 15 | 25281560 | |
| Pubmed | KDM3A KCNH8 HIPK1 RPS6KA3 GCK PTK2 DMXL1 KAT2B RPS6KA6 AKT1 ULK1 PLXNA1 DNAH10 GRB2 BRD2 TUBE1 | 5.37e-06 | 730 | 199 | 16 | 34857952 | |
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 5.77e-06 | 21 | 199 | 4 | 24025145 | |
| Pubmed | HAUS6 MYCBP2 ERC1 LIN54 ZNF462 WIZ UTRN DNAJC13 ZSCAN4 CHD8 ZKSCAN3 CCT8 | 5.92e-06 | 418 | 199 | 12 | 34709266 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | TIPRL WIZ SF3B2 POLDIP3 SMCHD1 CHD8 THOC2 PPP1R10 CCT8 PRKDC | 6.00e-06 | 283 | 199 | 10 | 30585729 |
| Pubmed | 6.00e-06 | 283 | 199 | 10 | 21903422 | ||
| Pubmed | VAPB ZNF346 MYO9A UGGT1 CHN1 NUP205 FGD4 ALDH18A1 NKTR PLOD2 UTRN ARHGEF6 LIMD1 GRB2 PPP1R10 FAM13A UTP4 DNAJC11 | 6.17e-06 | 916 | 199 | 18 | 32203420 | |
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 11212352 | ||
| Pubmed | UGGT1 ITPRID2 F5 HNRNPA1 NUP205 SAFB ALDH18A1 POLDIP3 SMCHD1 THOC2 BRD2 UTP4 MACF1 PRKDC LRRFIP1 | 6.93e-06 | 660 | 199 | 15 | 32780723 | |
| Pubmed | EPC2 CCDC8 ERG LIN54 GON4L NUP205 ZNF462 KAT2B WIZ SYNE2 HSPA4 LIMD1 DNAH10 POLDIP3 SMCHD1 CHD8 PATL1 TRIM33 BRD2 ZKSCAN3 UNK PABPC1L ELK3 | 8.35e-06 | 1429 | 199 | 23 | 35140242 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.05e-05 | 130 | 199 | 7 | 35545047 | |
| Pubmed | SPATA7 HAUS6 CCDC8 LIN54 LRRK2 HNRNPA1 DMXL1 TASOR2 WIZ ALDH18A1 DNAJC13 PPFIBP1 AP4E1 TRIM33 CCT8 PRKDC | 1.16e-05 | 777 | 199 | 16 | 35844135 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.20e-05 | 25 | 199 | 4 | 8493579 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.28e-05 | 134 | 199 | 7 | 25452129 | |
| Pubmed | P90 Ribosomal s6 kinase 2 negatively regulates axon growth in motoneurons. | 1.51e-05 | 9 | 199 | 3 | 19555761 | |
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 21775285 | ||
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 15582777 | ||
| Pubmed | VAPB STAM2 HAUS6 MYO9A ERC1 TIPRL HNRNPA1 GCLM ALDH18A1 HSPA4 SF3B2 PPFIBP1 CCT8 MACF1 PRKDC | 1.58e-05 | 708 | 199 | 15 | 39231216 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYCBP2 ERC1 UGGT1 GAS8 TIPRL CMYA5 COPS2 MYCBPAP PTK2 NUP205 PIK3R4 GCLM ULK1 PLOD2 SF3B2 PLEKHB2 PPFIBP1 PKD1L3 IBTK GSTK1 VPS35 | 1.67e-05 | 1284 | 199 | 21 | 17353931 |
| Pubmed | 1.84e-05 | 322 | 199 | 10 | 26514267 | ||
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 2.15e-05 | 10 | 199 | 3 | 19826009 | |
| Pubmed | Hsp70 associates with Rictor and is required for mTORC2 formation and activity. | 2.15e-05 | 10 | 199 | 3 | 18505677 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A TOPAZ1 RNF112 LAMA1 OBSCN CHN1 NUP205 WIZ ALDH18A1 UTRN ZNF675 CCT8 PWWP3B PRKDC TUBE1 | 2.48e-05 | 736 | 199 | 15 | 29676528 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VAPB UGGT1 KIAA0586 CMYA5 HNRNPA1 NUP205 PIK3R4 SAFB RPTOR ALDH18A1 HSPA4 SF3B2 PLXNA1 DNAH10 POLDIP3 SMCHD1 THOC2 UTP4 DNAJC11 VPS35 CCT8 PRKDC | 2.51e-05 | 1425 | 199 | 22 | 30948266 |
| Pubmed | 2.63e-05 | 101 | 199 | 6 | 10997877 | ||
| Pubmed | MYO9A HIPK1 ITPRID2 PTK2 RGL1 NKTR CPLANE1 RAP1GDS1 GRB2 CHD8 MACF1 PRKDC | 2.64e-05 | 486 | 199 | 12 | 20936779 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | MYO9A TIPRL NUP205 PHKG2 UTRN HSPA4 SF3B2 LIMD1 GRB2 ANKRD44 PPP1R10 CCT8 PRKDC | 2.93e-05 | 573 | 199 | 13 | 28330616 |
| Pubmed | 2.94e-05 | 11 | 199 | 3 | 33052068 | ||
| Pubmed | 2.94e-05 | 11 | 199 | 3 | 28059666 | ||
| Pubmed | VAPB ZNF346 CCDC8 UGGT1 TIPRL COPS2 HNRNPA1 NUP205 ASCC2 ALDH18A1 PLOD2 HSPA4 SF3B2 POLDIP3 GRB2 RNF220 WDR87 VPS35 PTRH2 CCT8 PRKDC | 2.95e-05 | 1335 | 199 | 21 | 29229926 | |
| Pubmed | CCDC8 MYO7A TASOR2 NUP205 DNAJC13 POLDIP3 PPFIBP1 DNAH1 USP40 MACF1 DISP1 KIF1C | 3.21e-05 | 496 | 199 | 12 | 31343991 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 18439899 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21658387 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15309026 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 9414314 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 9005995 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 26579576 | ||
| Pubmed | DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair. | 3.26e-05 | 2 | 199 | 2 | 33404607 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 33174020 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 31365290 | ||
| Pubmed | DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. | 3.26e-05 | 2 | 199 | 2 | 22131882 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 2070088 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 32631998 | ||
| Pubmed | The serine/threonine kinase ULK1 is a target of multiple phosphorylation events. | 3.26e-05 | 2 | 199 | 2 | 21819378 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 9373273 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 28820394 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 27306838 | ||
| Pubmed | Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis. | 3.26e-05 | 2 | 199 | 2 | 8844207 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 27764812 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 29361535 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 2346784 | ||
| Pubmed | YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion. | 3.26e-05 | 2 | 199 | 2 | 21559405 | |
| Pubmed | ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. | 3.26e-05 | 2 | 199 | 2 | 27023913 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 12878595 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21209368 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 18644989 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 1634521 | ||
| Pubmed | HSPA4 regulated glioma progression via activation of AKT signaling pathway. | 3.26e-05 | 2 | 199 | 2 | 37339521 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 17113264 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16891417 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 1391962 | ||
| Pubmed | Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers. | 3.26e-05 | 2 | 199 | 2 | 35929078 | |
| Pubmed | Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. | 3.26e-05 | 2 | 199 | 2 | 15492010 | |
| Interaction | YWHAG interactions | VAPB STAM2 CCDC8 MYCBP2 MYO9A ERC1 RPS6KA3 LRRK2 ITPRID2 MELK PTK2 PIK3R4 RPTOR SYNE2 AKT1 NKTR ULK1 UTRN HSPA4 ARHGEF6 FOXO6 LIMD1 PPFIBP1 GRB2 PPP4R4 FAM13A UNK MACF1 PRKDC PDE7B AHNAK2 KIF1C | 3.99e-07 | 1248 | 195 | 32 | int:YWHAG |
| Interaction | YWHAH interactions | VAPB STAM2 CCDC8 MYCBP2 MYO9A ERC1 RPS6KA3 LRRK2 ITPRID2 MELK MEX3C PIK3R4 RPTOR SYNE2 NKTR UTRN HSPA4 ARHGEF6 FOXO6 LIMD1 PPFIBP1 GRB2 PPP4R4 FAM13A MACF1 RIMS2 AHNAK2 KIF1C | 2.78e-06 | 1102 | 195 | 28 | int:YWHAH |
| Interaction | CALM1 interactions | CCDC8 MYCBP2 MYO7A MYO10 LRRK2 OBSCN ITPRID2 DMXL1 PHKG2 GCLM SYNE2 AKT1 UTRN HSPA4 DNAJC13 TRIM33 PDE4DIP UNK TRPV4 KIF1C | 3.07e-06 | 626 | 195 | 20 | int:CALM1 |
| Interaction | YWHAE interactions | VAPB CCDC8 MYCBP2 MYO9A ERC1 LRRK2 ITPRID2 MELK HNRNPA1 MEX3C PIK3R4 RPTOR AKT1 ULK1 HSPA4 SF3B2 VCAM1 UBR2 RAP1GDS1 RASGRF1 PPFIBP1 GRB2 PPP4R4 FAM13A UNK MACF1 RIMS2 PDE7B KIF1C | 1.15e-05 | 1256 | 195 | 29 | int:YWHAE |
| Interaction | YWHAB interactions | VAPB MYCBP2 MYO9A ERC1 RPS6KA3 LRRK2 ITPRID2 MELK HNRNPA1 PIK3R4 USP32 HSPA4 VCAM1 FOXO6 RASGRF1 PPFIBP1 GRB2 PPP4R4 TRIM33 FAM13A UNK MACF1 PDE7B AHNAK2 KIF1C | 1.67e-05 | 1014 | 195 | 25 | int:YWHAB |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.11e-04 | 206 | 135 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.13e-03 | 7 | 135 | 2 | 1113 | |
| GeneFamily | ETS transcription factor family | 1.16e-03 | 28 | 135 | 3 | 534 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.50e-03 | 66 | 135 | 4 | 722 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | WWC3 HNRNPA1 ADCY3 PTK2 MEX3C DMXL1 PTPRC PSME4 SYNE2 NIPA2 ADAM17 DNAJC13 RAP1GDS1 SMCHD1 TRIM33 PPP1R10 RRN3 CSPG4 PDE4DIP PTRH2 MACF1 PRKDC VPS28 LRRFIP1 AHNAK2 | 1.65e-09 | 790 | 198 | 25 | M12490 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A MYCBP2 MYO10 ERC1 RPS6KA3 TIPRL MELK PTK2 PIK3R4 RGL1 PSME4 SYNE2 ADAM17 PLOD2 UBR2 DNAJC13 SMCHD1 THOC2 TRIM33 IBTK SLC35A3 MACF1 PALS2 LRRFIP1 | 3.62e-08 | 856 | 198 | 24 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 9.80e-06 | 180 | 198 | 9 | M8239 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.45e-05 | 189 | 198 | 9 | M3112 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KDM3A HAUS6 MYO9A GON4L COPS2 RGL1 GCLM ADAM17 ULK1 HSPA4 PLEKHB2 UBR2 TRIM33 IBTK BRD2 FAM13A PDE4DIP CTH AHNAK2 | 1.66e-05 | 822 | 198 | 19 | M6782 |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | 2.27e-05 | 200 | 198 | 9 | M9842 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 2.27e-05 | 200 | 198 | 9 | M78 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 6.06e-05 | 176 | 198 | 8 | M8248 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 9.62e-05 | 97 | 198 | 6 | M14698 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 1.02e-04 | 141 | 198 | 7 | M7720 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN | 1.03e-04 | 190 | 198 | 8 | M7317 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 1.33e-04 | 197 | 198 | 8 | M8271 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 1.33e-04 | 197 | 198 | 8 | M9916 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.38e-04 | 198 | 198 | 8 | M7948 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | 1.42e-04 | 199 | 198 | 8 | M4650 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 1.42e-04 | 199 | 198 | 8 | M7821 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 1.42e-04 | 199 | 198 | 8 | M9236 | |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 1.47e-04 | 200 | 198 | 8 | M4768 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.47e-04 | 200 | 198 | 8 | M9889 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP | 1.47e-04 | 200 | 198 | 8 | M7235 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M7649 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HAUS6 MYCBP2 MYO9A MYO10 TM7SF3 DMXL1 TASOR2 SYNE2 NKTR CPLANE1 PARPBP DNAJC13 SMCHD1 KIF16B TRIM33 | 1.49e-04 | 656 | 198 | 15 | M18979 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | VAPB BNC2 ETV1 CLSTN2 FHIP1B DMXL1 ZNF462 TMEM132C BNC1 RGL1 SYNE2 NKTR CPLANE1 PLOD2 UTRN DNMT3A DNAJC13 CHD8 THOC2 BRD2 ZKSCAN3 USP40 TUBE1 | 9.47e-07 | 801 | 191 | 23 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | VAPB BNC2 MYO10 KIAA0586 DMXL1 ZNF462 BNC1 RGL1 SYNE2 NKTR CPLANE1 PLOD2 UTRN DNMT3A DNAJC13 CHD8 THOC2 LEFTY2 BRD2 ZKSCAN3 USP40 TUBE1 | 3.77e-06 | 806 | 191 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | VAPB BNC2 DMXL1 BNC1 RGL1 SYNE2 NKTR CPLANE1 PLOD2 UTRN DNMT3A DNAJC13 CHD8 ZKSCAN3 TUBE1 | 5.33e-06 | 413 | 191 | 15 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | VAPB KIAA0586 CLSTN2 SYNE2 RPS6KA6 NKTR CPLANE1 UTRN DNMT3A DNAJC13 CHD8 THOC2 TUBE1 | 7.74e-06 | 323 | 191 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | VAPB BNC2 FHIP1B DMXL1 ZNF462 TMEM132C BNC1 SYNE2 NKTR CPLANE1 PLOD2 UTRN DNMT3A DNAJC13 CHD8 THOC2 BRD2 ZKSCAN3 USP40 TUBE1 AHNAK2 | 9.51e-06 | 790 | 191 | 21 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | VAPB BNC2 SPTA1 KIAA0586 CLSTN2 DMXL1 ZNF462 BNC1 RGL1 SYNE2 RPS6KA6 NKTR CPLANE1 UTRN DNMT3A DNAJC13 CHD8 THOC2 BRD2 ZKSCAN3 TUBE1 | 1.52e-05 | 815 | 191 | 21 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.99e-05 | 127 | 191 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | MYCBP2 MYO10 GON4L TTC19 CPLANE1 PARPBP UTRN CEP164 IBTK SLC35A3 LRRFIP1 | 2.58e-05 | 261 | 191 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 ZSCAN12 MYO9A ERC1 HIPK1 LIN54 KIAA0586 GON4L CHN1 C17orf75 SYNE2 RPS6KA6 NKTR CPLANE1 HSPA4 UBR2 HELQ CEP164 ZKSCAN3 MACF1 | 2.62e-05 | 780 | 191 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.22e-05 | 41 | 191 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | VAPB BNC2 ETV1 DMXL1 ZNF462 TMEM132C SYNE2 NKTR CPLANE1 PLOD2 UTRN DNMT3A DNAJC13 COL12A1 CHD8 THOC2 BRD2 ZKSCAN3 TUBE1 AHNAK2 | 3.68e-05 | 799 | 191 | 20 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | CLSTN2 DMXL1 SYNE2 NKTR CPLANE1 UTRN DNMT3A DNAJC13 CHD8 THOC2 USP40 | 4.15e-05 | 275 | 191 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | SPTA1 KIAA0586 SYNE2 NKTR CPLANE1 UTRN DNMT3A DNAJC13 CHD8 THOC2 | 4.64e-05 | 230 | 191 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 5.10e-05 | 45 | 191 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.68e-05 | 147 | 191 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.92e-05 | 25 | 191 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.62e-05 | 203 | 191 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.63e-04 | 90 | 191 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SPATA7 EPC2 HAUS6 MYCBP2 KIAA0586 GAS8 PIK3R4 RPS6KA6 PARPBP UTRN SMCHD1 THOC2 AP4E1 TRIM33 MACF1 | 1.88e-04 | 564 | 191 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.09e-04 | 225 | 191 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | VAPB TMEM132C SYNE2 NKTR UTRN DNMT3A DNAJC13 COL12A1 ZKSCAN3 TUBE1 | 2.41e-04 | 281 | 191 | 10 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.56e-04 | 138 | 191 | 7 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | BNC2 MYO10 ETV1 C17orf75 RPTOR CPLANE1 UTRN DNMT3A IBTK SLC35A3 TUBE1 PDE7B | 2.66e-04 | 397 | 191 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | MYCBP2 MYO10 GON4L F5 TTC19 FGD4 PDP2 CPLANE1 PARPBP UTRN LIMD1 CEP164 IBTK SLC35A3 TRPV4 CTH PDE7B LRRFIP1 | 2.74e-04 | 786 | 191 | 18 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | VAPB BNC2 ETV1 CLSTN2 DMXL1 TMEM132C SYNE2 NKTR CPLANE1 UTRN DNMT3A DNAJC13 COL12A1 CHD8 THOC2 BRD2 TUBE1 AHNAK2 | 3.24e-04 | 797 | 191 | 18 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | BNC2 DMXL1 TMEM132C BNC1 SYNE2 NKTR CPLANE1 UTRN DNAJC13 CHD8 ZKSCAN3 TUBE1 | 3.25e-04 | 406 | 191 | 12 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CPNE2 EPC2 MYO10 KIAA0586 FGD4 MANEAL SYNE2 HSPA4 CHD8 RIMS2 | 3.84e-04 | 298 | 191 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | BNC2 SPTA1 CLSTN2 DMXL1 ZNF462 BNC1 RGL1 SYNE2 DNMT3A CHD8 ZKSCAN3 TUBE1 | 4.13e-04 | 417 | 191 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 4.17e-04 | 107 | 191 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.61e-04 | 152 | 191 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_200 | 5.29e-04 | 18 | 191 | 3 | gudmap_developingGonad_P2_epididymis_200_k4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HIPK1 TASOR2 PTPRC SYNE2 NKTR UTRN SMCHD1 ANKRD44 PPP1R10 FAM13A MACF1 | 9.37e-10 | 188 | 199 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.80e-09 | 200 | 199 | 11 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCDC8 MYO9A ADCY3 ADAM17 PLXNA1 VCAM1 PLEKHB2 RAP1GDS1 DNAH10 MX1 | 3.50e-09 | 163 | 199 | 10 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCDC8 MYO9A ADCY3 ADAM17 PLXNA1 VCAM1 PLEKHB2 RAP1GDS1 DNAH10 MX1 | 3.50e-09 | 163 | 199 | 10 | fd243ca223079033be480a24817a399f281fa4d4 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-08 | 200 | 199 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-08 | 151 | 199 | 9 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-08 | 157 | 199 | 9 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.66e-07 | 186 | 199 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-07 | 189 | 199 | 9 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.99e-07 | 190 | 199 | 9 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.70e-07 | 197 | 199 | 9 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.82e-07 | 198 | 199 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.82e-07 | 198 | 199 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 200 | 199 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.27e-07 | 156 | 199 | 8 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 6.39e-07 | 160 | 199 | 8 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 177 | 199 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.55e-06 | 180 | 199 | 8 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.55e-06 | 180 | 199 | 8 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 181 | 199 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 182 | 199 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.90e-06 | 185 | 199 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 189 | 199 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.41e-06 | 191 | 199 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 191 | 199 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-06 | 193 | 199 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 137 | 199 | 7 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 199 | 199 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 200 | 199 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.40e-06 | 200 | 199 | 8 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.40e-06 | 200 | 199 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.40e-06 | 200 | 199 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 200 | 199 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.51e-06 | 162 | 199 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.98e-06 | 166 | 199 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.21e-05 | 171 | 199 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 173 | 199 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 174 | 199 | 7 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 176 | 199 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 178 | 199 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-05 | 178 | 199 | 7 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 178 | 199 | 7 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-05 | 178 | 199 | 7 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 1.75e-05 | 181 | 199 | 7 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.75e-05 | 181 | 199 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 182 | 199 | 7 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 182 | 199 | 7 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-05 | 183 | 199 | 7 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 184 | 199 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 184 | 199 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 184 | 199 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 2.16e-05 | 187 | 199 | 7 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 2.16e-05 | 187 | 199 | 7 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-05 | 187 | 199 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 187 | 199 | 7 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | VE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 2.23e-05 | 188 | 199 | 7 | fa88ceb336e30de3585e62608527a0d44df74190 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 188 | 199 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | VE-Treg|VE / Condition, Cell_class and T cell subcluster | 2.23e-05 | 188 | 199 | 7 | ef048517dfe2fc995d13eb1f08106a487354a4cc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.23e-05 | 188 | 199 | 7 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 189 | 199 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 189 | 199 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.31e-05 | 189 | 199 | 7 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 189 | 199 | 7 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 189 | 199 | 7 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 190 | 199 | 7 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 190 | 199 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 190 | 199 | 7 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 190 | 199 | 7 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.47e-05 | 191 | 199 | 7 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 191 | 199 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 192 | 199 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.55e-05 | 192 | 199 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 192 | 199 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.64e-05 | 193 | 199 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.64e-05 | 193 | 199 | 7 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 193 | 199 | 7 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.64e-05 | 193 | 199 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-05 | 194 | 199 | 7 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 196 | 199 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.91e-05 | 196 | 199 | 7 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.01e-05 | 197 | 199 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.01e-05 | 197 | 199 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.11e-05 | 198 | 199 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| Drug | C.I. 337 | 3.82e-07 | 54 | 195 | 7 | CID006331826 | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | SPATA7 STAM2 MYO9A ITPRID2 COPS2 PSME4 AKT1 NKTR HSPA4 PLEKHB2 RRN3 | 1.24e-06 | 199 | 195 | 11 | 1055_DN |
| Drug | plakin | 6.71e-06 | 82 | 195 | 7 | CID000018752 | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.76e-06 | 196 | 195 | 10 | 2090_DN | |
| Drug | S 131 | 8.76e-06 | 16 | 195 | 4 | CID005744397 | |
| Disease | amygdala volume change measurement | 1.36e-04 | 16 | 189 | 3 | EFO_0021490 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 2.43e-04 | 4 | 189 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | Hereditary elliptocytosis | 2.43e-04 | 4 | 189 | 2 | cv:C0013902 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.82e-04 | 206 | 189 | 7 | C0152013 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 4.03e-04 | 5 | 189 | 2 | cv:C0037889 | |
| Disease | JOUBERT SYNDROME 17 | 4.03e-04 | 5 | 189 | 2 | C3553264 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 4.03e-04 | 5 | 189 | 2 | C0221409 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.41e-04 | 157 | 189 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Elliptocytosis, Hereditary | 6.02e-04 | 6 | 189 | 2 | C0013902 | |
| Disease | Ciliopathies | 7.27e-04 | 110 | 189 | 5 | C4277690 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.02e-03 | 31 | 189 | 3 | C1335167 | |
| Disease | Hereditary spherocytosis | 1.11e-03 | 8 | 189 | 2 | C0037889 | |
| Disease | Ewings sarcoma | 1.11e-03 | 8 | 189 | 2 | C0553580 | |
| Disease | Situs ambiguous | 1.43e-03 | 9 | 189 | 2 | C1167664 | |
| Disease | Kartagener Syndrome | 1.46e-03 | 35 | 189 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.46e-03 | 35 | 189 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.46e-03 | 35 | 189 | 3 | C4317124 | |
| Disease | Parkinson's disease (is_implicated_in) | 1.46e-03 | 76 | 189 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Facies | 1.78e-03 | 10 | 189 | 2 | C0282631 | |
| Disease | macrovascular complications of diabetes | 1.78e-03 | 10 | 189 | 2 | EFO_0010977 | |
| Disease | osteonecrosis (is_implicated_in) | 1.78e-03 | 10 | 189 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | Hodgkins lymphoma | 1.93e-03 | 82 | 189 | 4 | EFO_0000183 | |
| Disease | urate measurement | BNC2 MYO9A GON4L GJA10 DNAJC13 GRB2 VARS2 DNAH1 ZNF675 AP4E1 CACNA2D4 FAM13A CSPG4 PALS2 | 1.97e-03 | 895 | 189 | 14 | EFO_0004531 |
| Disease | Profound Mental Retardation | 2.06e-03 | 139 | 189 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.06e-03 | 139 | 189 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.06e-03 | 139 | 189 | 5 | C0917816 | |
| Disease | hair colour measurement | BNC2 GAS8 ETV1 BNC1 SYNE2 PLXNA1 FOXO6 EMB PKD1L3 FAM13A PALS2 | 2.15e-03 | 615 | 189 | 11 | EFO_0007822 |
| Disease | cocaine use | 2.16e-03 | 11 | 189 | 2 | C3496069 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.19e-03 | 206 | 189 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | forced expiratory volume, response to bronchodilator | 2.40e-03 | 445 | 189 | 9 | EFO_0004314, GO_0097366 | |
| Disease | FEV/FEC ratio | BNC2 TRIT1 WWC3 ERC1 SPEF2 KIAA0586 ETV1 COPS2 ADCY3 ZNF354C PTK2 SYNE2 ASCC2 HSPA4 TRIM33 FAM13A CSPG4 | 2.43e-03 | 1228 | 189 | 17 | EFO_0004713 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.47e-03 | 145 | 189 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.50e-03 | 364 | 189 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | calcium measurement | HPSE2 COPS2 SYNE2 DNMT3A CHD8 PPP4R4 USP40 PTRH2 MACF1 PDE7B MINDY1 | 2.53e-03 | 628 | 189 | 11 | EFO_0004838 |
| Disease | spleen volume | 2.64e-03 | 43 | 189 | 3 | EFO_0600047 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 3.04e-03 | 13 | 189 | 2 | C0238288 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 3.21e-03 | 46 | 189 | 3 | EFO_0008003, GO_0097332 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.31e-03 | 224 | 189 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | apolipoprotein A 1 measurement | CPNE2 LIN54 NUP205 TRANK1 PDP2 AKT1 DNAH10 PKD1L3 CEP164 FAM13A MACF1 MINDY1 LRRFIP1 | 3.36e-03 | 848 | 189 | 13 | EFO_0004614 |
| Disease | Paroxysmal atrial fibrillation | 3.39e-03 | 156 | 189 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 3.39e-03 | 156 | 189 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.39e-03 | 156 | 189 | 5 | C2585653 | |
| Disease | Primary Ciliary Dyskinesia | 3.41e-03 | 47 | 189 | 3 | C4551720 | |
| Disease | age at menopause | 3.45e-03 | 302 | 189 | 7 | EFO_0004704 | |
| Disease | Atrial Fibrillation | 3.77e-03 | 160 | 189 | 5 | C0004238 | |
| Disease | Malignant neoplasm of breast | KDM3A RPS6KA3 OBSCN PIK3R4 RGL1 PTPRC SYNE2 AKT1 DNMT3A KIF16B HELQ MACF1 ELK3 LGR6 LRRFIP1 | 4.00e-03 | 1074 | 189 | 15 | C0006142 |
| Disease | Situs ambiguus | 4.06e-03 | 15 | 189 | 2 | C0266642 | |
| Disease | B-cell acute lymphoblastic leukemia | 4.06e-03 | 15 | 189 | 2 | EFO_0000094 | |
| Disease | red blood cell density measurement | TRIT1 ERG MYO9A SPTA1 LIN54 NUP205 ZNF462 KAT2B PTPRC DNMT3A DNAH10 TRIM33 FAM13A | 4.57e-03 | 880 | 189 | 13 | EFO_0007978 |
| Disease | Polyposis, Adenomatous Intestinal | 4.62e-03 | 16 | 189 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 4.62e-03 | 16 | 189 | 2 | C2713443 | |
| Disease | obesity | 4.72e-03 | 241 | 189 | 6 | EFO_0001073 | |
| Disease | Adenomatous Polyposis Coli | 5.21e-03 | 17 | 189 | 2 | C0032580 | |
| Disease | sexual dimorphism measurement | ZNF346 ADCY3 ZNF462 TRANK1 DNMT3A FOXO6 DNAH10 RASGRF1 SPATA31C2 GRB2 PKD1L3 CEP164 RRN3 AVIL MACF1 | 5.22e-03 | 1106 | 189 | 15 | EFO_0021796 |
| Disease | aspartate aminotransferase measurement | WWC3 MYO7A OBSCN ETV1 HPSE2 RGL1 PTPRC DNAJC13 KIF16B GRB2 PDPK2P FAM13A PDE7B | 5.70e-03 | 904 | 189 | 13 | EFO_0004736 |
| Disease | Glioblastoma Multiforme | 5.73e-03 | 111 | 189 | 4 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEQEKKPLRQMIDSH | 136 | Q86Y25 | |
| AEEMEVSLAKPKHRV | 131 | P31749 | |
| HDDKPNIVLIMVDDL | 26 | P54793 | |
| IMDRISTEHDPVLKQ | 461 | Q52LR7 | |
| LLHTKPEVAAQERMV | 376 | O75366 | |
| MEEPNHLDVDLETRI | 2301 | Q9HCK8 | |
| DREKMSVRDHDPEVL | 36 | Q5TEZ4 | |
| EETRHAVVQASKLPM | 451 | Q96FN4 | |
| LLQELERHMEDTHPD | 386 | Q15052 | |
| NIMDDPFIREHIEEL | 336 | P61201 | |
| HVQPTLDLMEAELRK | 451 | Q6UVK1 | |
| NPVMIDAKEVSAAHR | 776 | Q9Y6K1 | |
| KVLMNSERPDENHSE | 751 | Q6ZN30 | |
| VASAPEVVDMQKRLH | 106 | Q9H1I8 | |
| KSHLRAQMENPDLDL | 111 | Q969M2 | |
| PKLLEALDEMLTHDI | 376 | Q9NZN4 | |
| DDVDKALQNSPRLMH | 206 | P11308 | |
| HAVEKINPDEREEMK | 76 | P48507 | |
| EKRHNLSSDEDMPLQ | 556 | Q01954 | |
| PAIMTHASVLKNDRD | 351 | P32929 | |
| KHMLDVENSPLIADD | 316 | Q5VUY2 | |
| DPKSEVLEEMLHNLD | 681 | Q9H4D0 | |
| THMLETDEENTKPRV | 1456 | Q9Y485 | |
| SLQRSIEEHLPKMAE | 1376 | Q96F81 | |
| LHENVELMKSLLPVD | 596 | Q9UPM8 | |
| EKSHLVPLMDARINA | 1106 | Q96L93 | |
| EEVDAAMNARPHKVD | 21 | A0A2R8Y4L2 | |
| PEMSDRIQHLEREIT | 731 | Q8IUD2 | |
| HEDSEKLREIVLPME | 146 | Q9H5N1 | |
| RAMLKHNLDSDPAEE | 681 | Q9NZL6 | |
| LHEKLNLPVENMDVT | 71 | Q9NWS1 | |
| DLMKLDHEEEPQLSE | 191 | Q96MZ0 | |
| RLETHEEASVKMLPT | 46 | P35557 | |
| HMVPLVEEINRLADE | 321 | Q96N11 | |
| RDDMIHQLPLLTEKQ | 291 | Q92621 | |
| VELDLNQAHMEETPK | 506 | Q14680 | |
| HVMLSQKPAVRDVDL | 431 | Q8N612 | |
| SLEEERPALMDDRKH | 546 | Q86TB9 | |
| HQVMVLDSEALRIPK | 536 | Q9NVH1 | |
| VLHKRLSQVDPEMAA | 161 | Q9H3H1 | |
| PERKTLMHLADAAEV | 636 | Q6MZP7 | |
| SLVEVHKSEENEEPM | 496 | P34932 | |
| ALTQRLEREMDAHPK | 451 | Q9UGP4 | |
| MTDSHVLEEAKKPRV | 431 | Q92831 | |
| RTERHEMQILSKPEF | 356 | Q6W5P4 | |
| PDREALAEHADLKSM | 306 | Q8NE63 | |
| AEAQHQKRDAMELPD | 876 | Q86W92 | |
| DLDELQLEMEDSKPH | 526 | Q9HBX8 | |
| LIHADLKPENIMLVD | 311 | Q86Z02 | |
| SALDLVMKDRPTHVV | 121 | Q9P2D0 | |
| KMERDILVEVNHPFI | 116 | P51812 | |
| DKLHVEMELSPDSQI | 721 | Q2LD37 | |
| IEDHPVLKEMEVQAN | 1336 | Q9UIW2 | |
| ESRLLAHLPKEMTQD | 256 | Q9NP56 | |
| INPEMKDRRHEESIL | 266 | A6NFA0 | |
| RPLLKTDMERHINEE | 431 | P50549 | |
| SPLELEQLDQHHEMK | 186 | Q96M96 | |
| MAAKLRAHQVDVDPD | 1 | A8MYZ6 | |
| PSRDEIEALIHRQEM | 1686 | Q9HD67 | |
| MVIHAPKEEEIETLN | 126 | Q8N8Q9 | |
| LRMERVIPLAQDHED | 866 | O43896 | |
| PQKEVITSDELMAHL | 156 | Q8N5J2 | |
| TSHKILVSEDMDEPR | 66 | A4QPB2 | |
| MKRHETSLPVQLEAL | 491 | Q5S007 | |
| DDLKIDLMPHDLITQ | 571 | Q9BSJ2 | |
| KMERDILVEVNHPFI | 121 | Q9UK32 | |
| PEEIRMLIHKTEDVN | 21 | Q8N8A2 | |
| HRDLKPENILLNEDM | 176 | Q6A1A2 | |
| LMLESPESLHAKIDE | 581 | Q4VXU2 | |
| IAQHPDVMLELQREK | 166 | Q8WWQ2 | |
| ASIPELLEHLQEMRE | 946 | O94988 | |
| PRAKAEEMLSKQRHD | 66 | P62993 | |
| TPEEEQELEKRVMEH | 776 | P28290 | |
| HEEMPEAKNVIAVLE | 371 | Q9HAS0 | |
| HEPMELLINDKVAQL | 356 | O95502 | |
| HRDLKPENILLDDNM | 151 | P15735 | |
| EEMRQLRESIAEHKP | 5821 | Q9UPN3 | |
| MLATLEPEQRAEIIH | 376 | P54886 | |
| VPTDDIHMKQVDLEN | 606 | O00469 | |
| SNILMVHPAREDIKI | 6591 | Q5VST9 | |
| EPLMEHRVLEEEAAR | 6916 | Q5VST9 | |
| MPDLSHLTEEERKII | 26 | Q9UQ26 | |
| KREIQMPHESVVEQE | 386 | Q86YG4 | |
| IAAPELETLRAMHKA | 456 | Q9NZW5 | |
| KREHPESEDRTIIME | 321 | Q9P2J9 | |
| PVDKDMELSHLRSRQ | 1326 | A1KZ92 | |
| EDLESMHPLLEEAAK | 2851 | Q9P2D7 | |
| ADQLPHVERKMLQDD | 501 | Q8WWV6 | |
| EKEAMSTIEPHRQVA | 636 | Q9Y4C1 | |
| RKEELNEMISHEQLP | 266 | O95393 | |
| RVPEADSQLTEKMTH | 786 | Q9H799 | |
| KNLPEDAIHTMIENL | 951 | Q99715 | |
| KNHDMVVVSPILERD | 156 | Q9UBR1 | |
| DIDPDHRKLSQLEAM | 691 | Q7Z3S7 | |
| EKSEAMLAEAHPEIR | 2596 | Q8N3K9 | |
| MLAEAHPEIREAKAV | 2601 | Q8N3K9 | |
| NLVLEKSSRDMPDHS | 2656 | Q8N3K9 | |
| VNLEHPEMLEKASRE | 106 | Q9Y2Q3 | |
| IEHDKREMIFEVLAP | 236 | P52306 | |
| KASLPSIQEELRHMA | 921 | Q3T8J9 | |
| EEVRHLKTKPSDEEM | 11 | P07108 | |
| ENLMLSILPKHVADE | 276 | O60266 | |
| SSDLVPEKDADRMHV | 666 | O75165 | |
| PEKDADRMHVRDNVK | 671 | O75165 | |
| LKMDPHAVEISRESL | 91 | P41970 | |
| ADMEKLVIPAHVRAQ | 46 | O00292 | |
| RDPEVLREHMTQLKE | 166 | Q5VSG8 | |
| RTKEPIQMDAEHREV | 606 | Q7Z4H7 | |
| IQMDAEHREVLPESL | 611 | Q7Z4H7 | |
| EHSSMPVEKNITLER | 66 | Q6PCB8 | |
| KMDPDHLVALVTEVI | 561 | Q8TDG4 | |
| SAKIMDPDEQLETLH | 366 | P15882 | |
| TLEDVARIMEKSTPH | 51 | Q9H0W5 | |
| HFKDDVEVVMRDPIL | 2716 | Q8IVF4 | |
| LETPKLEEAEMVENH | 2771 | Q8TDX9 | |
| EMSEHPSQTVRKALD | 751 | Q32MZ4 | |
| KMTVNNLHPRVTEED | 281 | Q9BY77 | |
| NVMKDLAVHTRLTPE | 401 | Q96J94 | |
| ASRHEANLLPMKEDL | 26 | O43903 | |
| AAIHRSMANPEELDK | 291 | Q96NZ1 | |
| ERLDQMVHPVAERLD | 301 | Q9NYV6 | |
| LDKAASHLRQLMDEP | 1041 | Q5ST30 | |
| DTHLVFRPLMEKVEV | 306 | Q969X6 | |
| HIEKIMAFREEIAPI | 2731 | P46939 | |
| EIHQRLMEEEKENQP | 1271 | Q9C093 | |
| LASLENHVKIEPADM | 831 | Q9UPN9 | |
| RAKLHIDEMDSVPTV | 196 | P19320 | |
| DDQTRQNIEDKVHMP | 36 | Q96CS7 | |
| RMISKPADSQDVHEL | 251 | A6NHR9 | |
| IELTHDPVANVRMKL | 611 | Q6NUP7 | |
| RENSRKPNLEKHEEM | 956 | B4DYI2 | |
| MKLEEPHVATLQDSR | 616 | Q8N3T6 | |
| EEEKRHLQEMANSLP | 1481 | Q8WXH0 | |
| TRKMHDRLEPEDEES | 706 | P12259 | |
| VKHTQPEDGVEMDTR | 536 | Q8NHL6 | |
| PDINIVLKQDMATEH | 1156 | P30414 | |
| KLHNEDAREPMAVTS | 516 | Q5H9M0 | |
| PASTHREIEMAQKLL | 976 | Q05397 | |
| ADLMTLSHREPKELD | 236 | P25391 | |
| MPENVDRAREEIEMH | 376 | Q5U5Q3 | |
| HPITKDLEAMRVQTE | 431 | Q8NB12 | |
| KRHTEPVEDILEMSL | 376 | Q7Z443 | |
| PLLVAHMEKLSQSEE | 1636 | O75592 | |
| EDSVIVRTMKPHAEL | 96 | O95785 | |
| LRPSELQEHMEQELE | 231 | Q5VTB9 | |
| RDKVHPMILAQEEDD | 141 | Q9BUU2 | |
| VMHDPELLTQERKAA | 986 | Q13972 | |
| VMKIPEEHDLESQIR | 971 | Q8N122 | |
| MKELPEQLQEHAIED | 171 | Q15424 | |
| PDHDVVAMARKLQDV | 431 | P25440 | |
| DKDEVAPQSAIHMDL | 4991 | Q8IVF2 | |
| APKLDHQRMDTIQED | 751 | P78536 | |
| MSPEKQHREEDEVDS | 1 | Q8TBZ0 | |
| SEVENALMKHPAVVE | 476 | Q68CK6 | |
| DASQELEISEHMKEP | 381 | Q9UPV0 | |
| LEISEHMKEPQLSDS | 386 | Q9UPV0 | |
| KEHDLAMINQLLDDP | 831 | G9CGD6 | |
| TQMIHREPDKRLEAE | 291 | Q99570 | |
| PDEETLIALLAHAKM | 121 | Q9Y3E5 | |
| SIMKDEPEEAELILH | 106 | Q6DKK2 | |
| KQLVARPDVVEMHDV | 466 | Q13435 | |
| EQPLEEERMHVGKNT | 631 | Q8N4P2 | |
| RPDLHTKEQILDMLV | 71 | P0CG00 | |
| IIEALANPEKERMKH | 616 | Q8NI27 | |
| TSPDEMAAQLHDLRK | 446 | Q9ULX5 | |
| MKELNEHADCVLPID | 196 | Q9UJT0 | |
| ADVEKLADELHMPSL | 31 | O75663 | |
| ERMKCFSEENHEPLR | 636 | Q96QK1 | |
| DEIQPDLRELMETMH | 151 | Q9UK41 | |
| VMVLPDENHREDALM | 731 | Q8TBZ2 | |
| EIKDDALQHSSPRAM | 331 | Q9P0W8 | |
| PMIDEKLEEIDRKHS | 331 | O75886 | |
| MPDTLEDLEVVQHRF | 876 | P11277 | |
| LMDSHPEQKEDIGQR | 1021 | P11277 | |
| ESHPDATEDLQRQKM | 1251 | P02549 | |
| LKPLMDVDEEIQNHV | 1541 | Q14997 | |
| PEEEERMHDELLQAV | 16 | Q3KNS6 | |
| QRDPTVHDDVLELEM | 2071 | P78527 | |
| EDMPLRDVIVHLTKQ | 146 | Q8NAM6 | |
| LEQEKEPLTVKRHEM | 56 | Q8TD23 | |
| LMDHLLSVPETVEKE | 391 | Q8N9V7 | |
| VEALHQNREMIDPDK | 171 | Q9UL40 | |
| EQPLEEERMHVGKNT | 631 | Q86WT1 | |
| QPEMHSKEQILELLV | 76 | Q9BRR0 | |
| VSREEIHPKEIMENS | 2446 | Q96JM2 | |
| RVLHDEILNKPMETL | 71 | Q9Y2D2 | |
| MAKVEQVLSLEPQHE | 1 | O95292 | |
| DLPDNVEEVKLLLHM | 781 | Q5VWN6 | |
| LAPNRDDENMDKTHL | 2346 | O15050 | |
| EEVDAAMNARPHKVD | 66 | P09651 | |
| MAHSELVKSLPEDEN | 791 | Q8IWV8 | |
| ASHAMIEKILSEEPR | 191 | Q9C0B0 | |
| TILRELEVQHPAAKM | 71 | P50990 | |
| TARRLSHDNMEEKVP | 446 | Q96QC0 | |
| RDDEKQLMNVEPIHA | 621 | P08575 | |
| QSEEEIDHPLMILKA | 336 | Q9NVE5 | |
| AIQAHMDQDEPLEVK | 6 | O43309 | |
| QHKEKMPEEEERLGR | 1786 | Q6ZQQ6 | |
| SKIENRHEMLAVEPI | 441 | Q9HBA0 | |
| PEETLMEQEHTEILR | 831 | O75385 | |
| KDNRTDDIPELHMDL | 301 | Q8NFA0 | |
| MDHINKLTQIEDPRE | 1 | Q9ULE0 | |
| LDPDELETITMHKIL | 646 | Q9NYU2 | |
| LHPRAIVMSVAKDEE | 1156 | Q9BVV6 | |
| LPENDLTEEMLLKHL | 201 | Q9NS93 | |
| LAPEDMSKEQVEEHV | 21 | O95995 | |
| PDELRSDITMHLNKE | 531 | Q96L42 | |
| QIKALEEPAVDMLHT | 461 | P20591 | |
| SMLEDRPTSNLEKLH | 1141 | Q13402 | |
| VKDFREKNTDHMRPD | 661 | B2RTY4 | |
| EKNTDHMRPDIVALL | 666 | B2RTY4 | |
| KQQLLHLLEEPTSME | 196 | Q5VU43 |